网站综合信息 www.newshome.com
    • 标题:
    • Home 
    • 关键字:
    • boehringer ingelheim boehringer ingleheim böhringer ingelheim boehr 
    • 描述:
    •  
    • 域名信息
    • 域名年龄:21年4天  注册日期:2003年12月06日  到期时间:2016年12月06日
      邮箱:abuse  电话:+34.935275235
      注册商:COREHUB, S.R.L. 
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • Google
    • 0  
    • 0  
    • pr:0  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 0  
    •  
    • 评级:0/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • 1,983,881  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • 43 
    • dmoz目录收录
    • -  
    • 流量走势图
    域名注册Whois信息

    newshome.com

    域名年龄: 21年4天
    注册时间: 2003-12-06
    到期时间: 2016-12-06
    注 册 商: COREHUB, S.R.L.
    注册邮箱: abuse
    联系电话: +34.935275235

    获取时间: 2015年06月17日 14:16:39
    Domain Name: NEWSHOME.COM
    Registrar: COREHUB, S.R.L.
    Sponsoring Registrar IANA ID: 15
    Whois Server: whois.corehub.net
    Referral URL: http://www.corehub.net
    Name Server: NS1.PERF1.COM
    Name Server: NS2.PERF1.FR
    Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
    Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
    Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
    Status: serverDeleteProhibited http://www.icann.org/epp#serverDeleteProhibited
    Status: serverTransferProhibited http://www.icann.org/epp#serverTransferProhibited
    Status: serverUpdateProhibited http://www.icann.org/epp#serverUpdateProhibited
    Updated Date: 2014-11-28
    Creation Date: 2003-12-06
    Expiration Date: 2016-12-06

    >>> Last update of whois database: Wed, 2015-Jun-17 06:24:25 GMT <<<

    For more information on Whois status codes, please visit
    https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.
    Domain Name: newshome.com
    Registry Domain ID: D-282627002-CONE
    Registrar WHOIS Server: whois.corehub.net
    Registrar URL: http://corehub.net
    Updated Date: 2014-11-20T11:51:03.773Z
    Creation Date: 2003-12-06T19:23:01.0Z
    Registrar Registration Expiration Date: 2016-12-06T19:23:01.0Z
    Registrar: CORE-111 (Nameshield)
    Registrar IANA ID: 15
    Registrar Abuse Contact Email: abuse
    Registrar Abuse Contact Phone: +34.935275235
    Reseller: http://www.nameshield.net
    Domain Status: clientDeleteProhibited https://www.icann.org/epp#clientDeleteProhibited
    Domain Status: clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited
    Domain Status: clientUpdateProhibited https://www.icann.org/epp#clientUpdateProhibited
    Registry Registrant ID: COCO-13591971
    Registrant Name: TRADEMARKS AND domains
    Registrant Organization: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Registrant Street: Binger Strasse 173
    Registrant City: INGELHEIM
    Registrant State/Province:
    Registrant Postal Code: D-55216
    Registrant Country: DE
    Registrant Phone: +49.6132778969
    Registrant Phone Ext:
    Registrant Fax: +49.6132779551
    Registrant Fax Ext:
    Registrant Email: domain.names
    Registry Admin ID: COCO-13573547
    Admin Name: TRADEMARKS AND domains
    Admin Organization: BOEHRINGER INGELHEIM GMBH
    Admin Street: Binger Strasse 173
    Admin City: INGELHEIM
    Admin State/Province:
    Admin Postal Code: D-55216
    Admin Country: DE
    Admin Phone: +49.6132778969
    Admin Phone Ext:
    Admin Fax: +49.6132779551
    Admin Fax Ext:
    Admin Email: domain.names
    Registry Tech ID: COCO-1299168
    Tech Name: TECHNICAL Department
    Tech Organization: NAMESHIELD
    Tech Street: 27 rue des arenes
    Tech City: ANGERS
    Tech State/Province:
    Tech Postal Code: 49100
    Tech Country: FR
    Tech Phone: +33.241182828
    Tech Phone Ext:
    Tech Fax: +33.241182829
    Tech Fax Ext:
    Tech Email: technical
    Name Server: ns1.perf1.com 81.92.86.46 2a01:c8:2:106::46
    Name Server: ns2.perf1.fr
    DNSSEC: unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net
    >>> Last update of WHOIS database: 2015-06-17T06:24:13.985Z <<<

    % (c) 2014 COREhub S.R.L.U. ("COREhub"). All rights reserved.
    %
    % NOTICE: Access to the domains information is provided to assist in
    % determining the contents of a domain name registration record in the
    % COREhub database. The data in this record is provided by COREhub for
    % informational purposes only, and COREhub does not guarantee its
    % accuracy. This service is intended only for query-based access.
    其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2015年06月17日 14:16:37
    网址:http://www.newshome.com/
    标题:Home
    关键字:boehringer-ingelheim, boehringer-ingleheim, böhringer-ingelheim, boehringer, böhringer, ingelheim, ingleheim
    描述:
    主体:
    HomeCountry websitesContactFAQFacebookTwitterSearchSubmitHomePress ReleasesEvents and InitiativesEducation Huboncologymetabolismrespiratorycardiovascular-strokeImage LibraryRLS - Restless Legs SyndromStroke Prevention in AFVenous ThromboembolismParkinson's DiseaseHistoryManagementManufacturingResearch & DevelopmentCopdDiabetesHIV / Aids BuildingsMedia Contacts This website is intended for journalists outside the US/UK/Canada, who are interested in media information from Boehringer Ingelheim.Latest Press Releases16.06.2015New publication in The Lancet describes effective reversal of Pradaxa® in healthy volunteers08.06.2015Type 2 diabetes: Patients reporting better quality of communication by their physician show improved self-care08.06.2015Empagliflozin/metformin demonstrates reductions in blood glucose in data presented at ADA - Type 2 diabetes03.06.2015NICE recommends VARGATEF® (nintedanib*) in combination with docetaxel as an option for patients with non-small cell lung cancer of adenocarcinoma histology within its licensed indication03.06.2015Respimat® success story: Boehringer Ingelheim invests EUR 72 million in production capacity in Ingelheim31.05.2015ASCO 2015: Superior overall survival for afatinib compared to erlotinib demonstrated in head-to-head trial in patients with previously treated advanced squamous cell carcinoma of the lung28.05.2015Type 2 diabetes: Synjardy® (empagliflozin/metformin hydrochloride) approved in the European Union28.05.2015Boehringer Ingelheim and researchers at The University of Michigan collaborate to study mechanisms of diabetic nephropathy in Pima Indians27.05.2015Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association’s® 75th Scientific SessionsTop Stories   Myths & Misconceptions - The Anticoagulation Debate #TellingMyStory for Stroke Awareness MonthprevnextEvents and InitiativesASCO 201514 May 2015Education Hub Tweets about "#oncology" INFOGRAPHICNintedanib* Lume-Lung 1 Clinical TrialINFOGRAPHICAfatinib* Lux-Lung 3 & 6 Clinical TrialsTweets from @Boehringer Back to topSitemapTerms of useRSS FeedPrint pageRecommend© 2010 - 2014 Boehringer Ingelheim GmbH All rights reservedLegal Text: This text contains legal text that has to be visible on all pages of the website. It is maintained in the client configuration. If it is required to have a special formatting for the legal text, it is recommend to insert that formatted text as an image in the respective entry of client configuration. Our company   Corporate homeAbout usAnnual reportAnnual press conferenceOther News CentresUSUKOur website by countryOur Countries A-ZArgentinaAustriaAustraliaBahrainBelarusBelgiumBosnia and HerzegovinaBrazilBulgariaCanadaChileChinaColombiaCroatiaCyprusCzech RepublicDenmarkEcuadorEgyptEstoniaEthiopiaFinlandFranceGermanyGermany HeadquartersGreeceGhanaHong Kong
    Hungary
    India
    Indonesia
    Iraq
    Irland
    Italy
    Japan
    Jordan
    Kenya
    Kuweit
    Latvia
    Lebanon
    Libya
    Lithuania
    Macedoni

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2024-12-04 15:53, Process in 0.0057 second.